$36,974.67 | Growth + High Yield Overview

Well, off to a good start I suppose? One week into my product life-cycle portfolio, I am beating the S&P 500. I shouldn’t be too excited yet, but I can’t help but be a little excited. My strategy to invest in post-vaccine and stocks that will benefit from economic recovery seemed to pay off thisContinue reading “$36,974.67 | Growth + High Yield Overview”